Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06876350 · ClinicalTrials.gov registry record · NA
Woodcasting Versus Thermoplast Splint in CMC Arthroplasty
A NA study of Carpometacarpal (CMC) Joint Arthritis, sponsored by Foundation for Orthopaedic Research and Education.
- Recruiting
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT06876350: Recruiting NA study of Carpometacarpal (CMC) Joint Arthritis, sponsored by Foundation for Orthopaedic Research and Education.
NCT06876350 is a NA study of Carpometacarpal (CMC) Joint Arthritis that is actively recruiting participants, run by Foundation for Orthopaedic Research and Education. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06876350, a NA study of Carpometacarpal (CMC) Joint Arthritis, is actively recruiting participants, sponsored by Foundation for Orthopaedic Research and Education.
- RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.
Primary Outcome
The satisfaction survey consists of three questions totaling 15. The minimum value is a 1, while the maximum value is 15. A higher score indicating highest satisfaction.
Conditions Studied
Interventions
- OTHER Woodcasting Splint
- OTHER Control (Standard treatment)
Study Locations (1)
Florida
- Florida Orthopaedic Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What NCT06876350 shows while recruiting
NCT06876350 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Carpometacarpal (CMC) Joint Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Woodcasting Splint is the first listed.
NCT06876350 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06876350 about?
NCT06876350 is a clinical study titled "Woodcasting Versus Thermoplast Splint in CMC Arthroplasty". This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.
What is the current status of trial NCT06876350?
This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2024-10-03. Estimated completion is 2025-06-30.
What conditions does trial NCT06876350 study?
This clinical trial studies the following conditions: Carpometacarpal (CMC) Joint Arthritis.
What interventions are being tested in trial NCT06876350?
The interventions under investigation include: Woodcasting Splint (OTHER), Control (Standard treatment) (OTHER).
Who is sponsoring clinical trial NCT06876350?
This trial is sponsored by Foundation for Orthopaedic Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06876350 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06876350's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI